Home / Resource Library / Comparison of CAR T-cell vs. bispecific antibody as third or later line large B cell lymphoma therapy: A Meta-analysisComparison of CAR T-cell vs. bispecific antibody as third or later line large B cell lymphoma therapy: A Meta-analysis